Envoy Medical, Inc. Class A Common Stock
Follow $COCH
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $COCH by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is COCH moving today?
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
COCH overview
Related filings and maps
Congress activity in COCH
No receipt-qualified Congressional disclosure is present for COCH in the cached public ledger.
COCH contract awards, year to date.
Public federal awards linked to this ticker.
COCH lobbying filings, year to date.
Registered lobbying filings matched to Envoy Medical, Inc. Class A Common Stock.